ATE198490T1 - Verfahren zur herstellung von fusionsproteinen, die scfv fragmente enthalten, in transformierten schimmelpilzen - Google Patents

Verfahren zur herstellung von fusionsproteinen, die scfv fragmente enthalten, in transformierten schimmelpilzen

Info

Publication number
ATE198490T1
ATE198490T1 AT94920443T AT94920443T ATE198490T1 AT E198490 T1 ATE198490 T1 AT E198490T1 AT 94920443 T AT94920443 T AT 94920443T AT 94920443 T AT94920443 T AT 94920443T AT E198490 T1 ATE198490 T1 AT E198490T1
Authority
AT
Austria
Prior art keywords
gene
aspergillus
present
scfv
mould
Prior art date
Application number
AT94920443T
Other languages
English (en)
Inventor
Leon Gerardus Joseph Frenken
Gorcom Robert F M Van
Johanna G M Hessing
Den Hondel Cornelis Antoni Van
Wouter Musters
Johannes Mariaa Verbakel
Cornelis Theodorus Verrips
Original Assignee
Unilever Nv
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv, Tno filed Critical Unilever Nv
Application granted granted Critical
Publication of ATE198490T1 publication Critical patent/ATE198490T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94920443T 1993-06-09 1994-06-09 Verfahren zur herstellung von fusionsproteinen, die scfv fragmente enthalten, in transformierten schimmelpilzen ATE198490T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP93201660 1993-06-09
EP93201661 1993-06-09
EP93201706 1993-06-14
PCT/EP1994/001906 WO1994029457A2 (en) 1993-06-09 1994-06-09 Process for producing fusion proteins comprising scfv fragments by a transformed mould

Publications (1)

Publication Number Publication Date
ATE198490T1 true ATE198490T1 (de) 2001-01-15

Family

ID=27235312

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920443T ATE198490T1 (de) 1993-06-09 1994-06-09 Verfahren zur herstellung von fusionsproteinen, die scfv fragmente enthalten, in transformierten schimmelpilzen

Country Status (10)

Country Link
EP (1) EP0702721B1 (de)
JP (1) JPH08511160A (de)
AT (1) ATE198490T1 (de)
AU (1) AU7123494A (de)
CA (1) CA2162878A1 (de)
DE (1) DE69426527T2 (de)
DK (1) DK0702721T3 (de)
ES (1) ES2155854T3 (de)
FI (1) FI114870B (de)
WO (1) WO1994029457A2 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504344D0 (en) * 1995-03-03 1995-04-19 Unilever Plc Antibody fragment production
DK0826054T3 (da) * 1995-05-18 2004-04-19 Genencor Int Ekspression af glycosyltransferase i Aspergillus
BR9810014A (pt) 1997-06-13 2000-09-12 Unilever Nv Enzima alvejante, anticorpo bi-especìfico, anticorpo multi-especìfico, anticorpo ou fragmento de anticorpo ou derivado deste, composição enzimática alvejante, processo para alvejar manchas presentes em tecidos, e, imunógeno
ATE535154T1 (de) 1998-03-12 2011-12-15 Vhsquared Ltd Produkten die inaktivierte hefen oder schimmel enthalten, die auf ihrer aussenoberfläche aktive antikörper haben
EP0954978B1 (de) 1998-03-12 2011-11-30 VHsquared Limited Produkten die inaktivierte Hefen oder Schimmel enthalten, die auf ihrer Aussenoberfläche aktive Antikörper haben
EP1196532A1 (de) 1999-07-27 2002-04-17 Unilever N.V. Bleichende waschmittelzusammensetzungen
WO2002050123A2 (en) 2000-12-19 2002-06-27 Unilever N.V. Stabilization of antibodies or fragments thereof
CA2474616A1 (en) * 2002-01-28 2003-08-07 Medarex, Inc. Human monoclonal antibodies to prostate specific membrane antigen (psma)
EP1888640B1 (de) 2005-05-18 2012-03-14 Ablynx N.V. Verbesserte nanokörper gegen tumornekrosefaktor-alpha
MX2007014564A (es) 2005-05-20 2008-02-07 Ablynx Nv Anticuerpos de vhh de dominio unico contra el factor de von willebrand.
US9156914B2 (en) 2006-12-19 2015-10-13 Ablynx N.V. Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
WO2008074839A2 (en) 2006-12-19 2008-06-26 Ablynx N.V. Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
EP2102240A2 (de) * 2007-01-05 2009-09-23 Novozymes A/S Überexpression des chaperon-bips in einem heterokaryon
CA2720763A1 (en) 2008-04-07 2009-10-15 Ablynx Nv Amino acid sequences directed against the notch pathways and uses thereof
CN105399828B (zh) 2009-04-10 2021-01-15 埃博灵克斯股份有限公司 用于治疗il-6r相关疾病和病症的改进的针对il-6r的氨基酸序列和包含其的多肽
CN102549012B (zh) 2009-05-07 2015-07-01 诺维信生物制药丹麦公司 纯化白蛋白的方法
HUE035773T2 (en) 2009-06-05 2018-05-28 Ablynx Nv Trivalent human airway giant cell virus (hrsv) nanotubes for preventing and / or treating respiratory infections
WO2011064382A1 (en) 2009-11-30 2011-06-03 Ablynx N.V. Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
WO2011073180A1 (en) 2009-12-14 2011-06-23 Ablynx N.V. Single variable domain antibodies against ox40l, constructs and therapeutic use
WO2011083141A2 (en) 2010-01-08 2011-07-14 Ablynx Nv Method for generation of immunoglobulin sequences by using lipoprotein particles
US9120855B2 (en) 2010-02-10 2015-09-01 Novartis Ag Biologic compounds directed against death receptor 5
US8937164B2 (en) 2010-03-26 2015-01-20 Ablynx N.V. Biological materials related to CXCR7
CN102906118B (zh) 2010-05-20 2017-07-28 埃博灵克斯股份有限公司 与her3相关的生物材料
EP2621953B1 (de) 2010-09-30 2017-04-05 Ablynx N.V. Biologische stoffe im zusammenhang mit c-met
JP5933573B2 (ja) 2010-11-08 2016-06-15 ノバルティス アーゲー Ｃｘｃｒ２結合ポリペプチド
US20150158948A9 (en) 2011-03-28 2015-06-11 Francis Descamps Bispecific anti-cxcr7 immunoglobulin single variable domains
UA117218C2 (uk) 2011-05-05 2018-07-10 Мерк Патент Гмбх Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
JP2014525736A (ja) 2011-06-23 2014-10-02 アブリンクス エン．ヴェー． ＩｇＥに対する免疫グロブリン単一可変ドメイン
JP6219287B2 (ja) 2011-09-30 2017-10-25 アブリンクス エン．ヴェー． ｃ−Ｍｅｔに関連する生物学的物質
US9328174B2 (en) 2012-05-09 2016-05-03 Novartis Ag Chemokine receptor binding polypeptides
WO2014087010A1 (en) 2012-12-07 2014-06-12 Ablynx N.V. IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
EP3071598B1 (de) 2013-05-29 2021-07-07 Vybion, Inc. Einkettige intrakörper zur modifizierung des huntingtin-mutanten-abbaus
NL2013661B1 (en) 2014-10-21 2016-10-05 Ablynx Nv KV1.3 Binding immunoglobulins.
PL3233910T3 (pl) 2014-12-19 2020-06-01 Ablynx N.V. Dimery nanociał połączone cysteiną
AU2016260909B2 (en) 2015-05-13 2019-08-22 Ablynx N.V. T cell recruiting polypeptides based on CD3 reactivity
EP3611192A3 (de) 2015-05-13 2020-03-25 Ablynx N.V. T-zell-rekrutierende polypeptide auf basis von tcr-alpa/beta-reaktivität
WO2017013270A1 (en) 2015-07-23 2017-01-26 Universite De Strasbourg Use of leptin signaling inhibitor for protecting kidneys from patients having ciliopathy
KR102588359B1 (ko) 2016-03-04 2023-10-13 제이엔 바이오사이언시즈 엘엘씨 Tigit에 대한 항체
US10968281B2 (en) 2016-10-14 2021-04-06 Institut Curie Anti-LSP1 antibody
WO2018091606A1 (en) 2016-11-16 2018-05-24 Ablynx Nv T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta
EP3624854A1 (de) 2017-05-16 2020-03-25 Université de Strasbourg Proteinwirkstoffkonjugate und deren verwendung in der behandlung von krebs
KR20200013247A (ko) 2017-06-02 2020-02-06 아블린쓰 엔.브이. 아그레칸 결합 면역글로불린
BR112019024333A2 (pt) 2017-06-02 2020-07-28 Merck Patent Gmbh imunoglobulinas de ligação adamts
US11813307B2 (en) 2017-06-02 2023-11-14 Merck Patent Gmbh Polypeptides binding ADAMTS5, MMP13 and aggrecan
WO2018220235A1 (en) 2017-06-02 2018-12-06 Merck Patent Gmbh Mmp13 binding immunoglobulins
US20200371105A1 (en) 2017-07-28 2020-11-26 Institut Curie New subpopulations of cancer associated fibroblasts as prognosis markers for immunotherapy treatments
TW202000238A (zh) 2018-02-26 2020-01-01 比利時商艾伯林克斯公司 編碼肽連接子之經改良核苷酸序列
KR101875564B1 (ko) * 2018-05-24 2018-07-09 국민대학교산학협력단 포도당 및 글리세롤을 이용한 유가식 배양을 통한 리시놀레산으로 오메가-하이드록시운덱-9-에논산의 생물전환공정
EP3636657A1 (de) 2018-10-08 2020-04-15 Ablynx N.V. Chromatographiefreies antikörperreinigungsverfahren
WO2020245663A1 (en) 2019-06-01 2020-12-10 Institut Pasteur Nanobody-based ns1 assay for the specific diagnosis of acute zika virus infection
IL298111A (en) 2020-06-02 2023-01-01 Arcus Biosciences Inc Antibodies to tigit
IL303740A (en) 2020-12-18 2023-08-01 Sanofi Sa Polypeptides that recruit T cells based on reactivity to alpha/beta receptors
EP4337691A1 (de) 2021-05-12 2024-03-20 Université de Strasbourg Für phosphoryliertes h2ax spezifischer einzeldomänenantikörper und dessen verwendungen
WO2023151894A1 (en) 2022-02-11 2023-08-17 Henkel Ag & Co. Kgaa Process for the synthesis of alpha-methylene-gamma-butyrolactone
US20240132624A1 (en) 2022-07-27 2024-04-25 Ablynx N.V. Polypeptides binding to a specific epitope of the neonatal fc receptor
WO2024083843A1 (en) 2022-10-18 2024-04-25 Confo Therapeutics N.V. Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2084189A1 (en) * 1990-07-16 1992-01-17 Alko Group Limited Immunoglobulin production by trichoderma
WO1993008300A1 (en) * 1991-10-18 1993-04-29 The University Of Calgary Expression-secretion vectors for the production of biologically active fv fragments
IT1270866B (it) * 1993-03-10 1997-05-13 Eniricerche Spa Vettore ricombinante e suo impiego per la preparazione esocellulare di anticorpi in forma di singola molecola da bacillus subtilis

Also Published As

Publication number Publication date
AU7123494A (en) 1995-01-03
WO1994029457A2 (en) 1994-12-22
EP0702721B1 (de) 2001-01-03
WO1994029457A3 (en) 1995-03-09
JPH08511160A (ja) 1996-11-26
FI955446A (fi) 1995-12-11
FI114870B (fi) 2005-01-14
DK0702721T3 (da) 2001-05-21
DE69426527T2 (de) 2001-08-30
DE69426527D1 (de) 2001-02-08
FI955446A0 (fi) 1995-11-13
ES2155854T3 (es) 2001-06-01
EP0702721A1 (de) 1996-03-27
CA2162878A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
ATE198490T1 (de) Verfahren zur herstellung von fusionsproteinen, die scfv fragmente enthalten, in transformierten schimmelpilzen
EP0042246B1 (de) Plasmid
US5981475A (en) Treatment for sensitive teeth
ATE97957T1 (de) Verfahren zur herstellung des rekombinanten menschlichen faktors viii:c.
DE69018920D1 (de) Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine.
FI973468A (fi) Hampaiden valkaisemiseen tai ihon ja limakalvojen sairauksien hoitoon käytettävien valmisteiden valmistusmenetelmä
EP0132732A3 (en) Homologues from aprotinine whose lys 15 amino acid is substituted by other amino acids, process for their preparation and their use as medicaments
MY110734A (en) Improvements in or relating to dioic acids.
ZA929539B (en) Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from an aspergillus endoxylanase II G
DE3471092D1 (en) Composition essentially consisting of trans-1-(2,6,6-trimethylcyclohexyl)-hexan-3-ol, utilization of same and process for its preparation; cycloaliphatic ketone and alcohol intermediates
ATE233314T1 (de) Eine sekretionssequenz für die herstellung von heterologen proteinen in hefe
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
Slavkin et al. Molecular aspects of tooth morphogenesis and differentiation
DE3175357D1 (en) Dna sequences encoding various allelic forms of mature thaumatin, recombinant plasmids comprising said dna's and a process for their preparation, bacterial cultures comprising said recombinant plasmids, and method for producing mature thaumatin
HUP9904219A2 (hu) Eljárás és készítmények interferon-alfa-nukleinsavak bevitelére és expressziójára
EP0587571A4 (de) Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen.
PT93614A (pt) Estirpe de levedura melhorada para a producao de proteinas heterologas maduras,em particular hirudina, e processo para a preparacao da hirudina correspondente
EP0952158A4 (de) Modifizierte methylotrophe p. pastoris hefe, welche menschliches wachstumshormon sekretiert
DE69530647D1 (de) Für biosynthetische Insulinvorstufen kodierende DNA-Sequenzen und Verfahren zur Herstellung von Insulin
WO1991005045A1 (en) PORCINE LACTOFERRIN AMINO ACID AND cDNA SEQUENCE
DE3767629D1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
AU4938993A (en) Method and product for diagnosis of collagen tissue destructive diseases such as periodontitis
AU1003797A (en) Novel HS gene, expression plasmid in which HS gene is ligated downstream of structural gene encoding foreign gene PR product, and process for producing foreign gene product using transformant containing the expression of plasmid
EP0184163A3 (de) Herstellung eines Multi-Kopien-Hefe-Vektors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties